Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses.
Tapia-Galisteo A, Sánchez-Rodríguez I, Narbona J, Iglesias-Hernández P, Aragón-García S, Jiménez-Reinoso A, Compte M, Khan S, Tsuda T, Chames P, Lacadena J, Álvarez-Vallina L, Sanz L.
Tapia-Galisteo A, et al. Among authors: khan s.
Oncoimmunology. 2024 Apr 13;13(1):2338558. doi: 10.1080/2162402X.2024.2338558. eCollection 2024.
Oncoimmunology. 2024.
PMID: 38623463
Free PMC article.